Synthetic human papillomavirus genes
US7001995B1 · kind B1 · utility
17Cited by
9References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 21, 2000 |
| Grant date | Feb 21, 2006 |
| Priority date | — |
| Expiry date | Apr 6, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Synthetic DNA molecules encoding papillomavirus proteins are provided. The codons of the synthetic molecules are codons preferred by the projected host cell. The synthetic molecules may be used as a polynucleotide vaccine which provides effective immunoprophylaxis against papillomavirus infection through stimulation of neutralizing antibody and cell-mediated immunity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.